Patent · US Active

Use of ligands derived from receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases

US12352761B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 7, 2019
Grant dateJul 8, 2025
Priority date
Expiry dateOct 16, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/15
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods for detecting and/or measuring the level of sodium-dependent multivitamin transporter (SMVT) in a biological sample. The methods include the steps of: (a) contacting the biological sample with a PERV-B.RBD ligand, a variant and/or a fragment thereof; and, detecting and/or measuring the binding of the PERV-B.RBD ligand, variant and/or fragment thereof to SMVT.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.